수의학 CDMO 회사|
수의학 제품 계약 제조 서비스

수의학 제품 계약 제조 및 개발을 위한 신뢰할 수 있는 파트너

적용된 필터:Veterinary×모두 지우기

전시 97 시설

정렬 기준:

이탈리아

Aenova Group - Location Latina, Italy

Aenova

Competence Center 동물 보건 제품 및 멸균 기술.

우리 시설을 찾아보세요

Markets: ANVISA (Brazil), FDA (USA), EMA (EU), Russian Health Authorities, Turkish Health Authorities, SFDA (Saudi Arabia)

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1, 2

Compliance: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), EMA (EU GMP), SFDA (Saudi Food & Drug Authority)

Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

슬로베니아

JAFRAL

R&D, 비GMP 및 GMP 제조, QC 테스트, 고급 생물학제제에 대한 충진 및 마감 서비스를 제공하는 통합 생명공학 시설입니다.

우리 시설을 찾아보세요

Markets: Health Canada (Canada), ANVISA (Brazil), FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), CDSCO (India), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), TGA (Australia)

Category / Product: COSMETICS, NUTRACEUTICALS, FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1, 2

Compliance: ISO, ICH, FDA (cGMP), World Health Organization (GMP / HACCP), EMA (EU GMP), SQF (Safe Quality Food)

Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

Controlled Substances: Lowest potential for abuse

Therapeutic Areas of Expertise (ATC): (D) Dermatologicals, (J) Antiinfectives for systemic use, (V06) Nutrients, (R) Respiratory system, (A) Digestive tract and metabolism

Region: Europe

인도

HIKAL | Mumbai

Hikal Ltd.

Hikal은 소분자, HPAPI, 공정 개발, 맞춤형 합성 및 상업 제조를 전문으로 하는 선도적인 제약 CDMO입니다.

우리 시설을 찾아보세요

Markets: Health Canada (Canada), ANVISA (Brazil), FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), CDSCO (India), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), MFDS (South Korea), TGA (Australia), 나머지 세계

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1, 2, 3, 4

Compliance: ISO, ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), ECOVADIS, World Health Organization (GMP / HACCP), Health Canada (Canada GMP), MHRA (UK GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), PMDA (Japan), ANVISA (Brazil), Health Canada

Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: SERVICES, CHEMICAL-SYNTHETIC

Region: APAC

스위스

CARBOGEN AMCIS | Bubendorf

CARBOGEN AMCIS

항체 약물 결합체(ADC)를 포함한 고효능 API의 개발 및 cGMP 제조.

우리 시설을 찾아보세요

Services: Development services, Analytical / QC services, Regulatory services, Quality Assurance services, Manufacturing services

Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), Turkish Health Authorities, CDSCO (India), TGA (Australia)

Compliance: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

Use: Human, Veterinary

Therapeutic Areas of Expertise (ATC): (V09-10) Radiopharmaceuticals, (N) Nervous system, (D) Dermatologicals, (B) Blood and blood forming organs, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism

Batch Size: Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: PARTICLE ENGINEERING, SERVICES, BIOLOGICS, CHEMICAL-SYNTHETIC

Region: Europe

스위스

CARBOGEN AMCIS | Aarau

CARBOGEN AMCIS

크로마토그래피를 포함한 개발 및 중간 규모 cGMP 제조.

우리 시설을 찾아보세요

Use: Human, Veterinary

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), CDSCO (India), MFDS (South Korea), TGA (Australia)

Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services

Compliance: ISO, FDA (cGMP), PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP)

Batch Size: Small, Medium

Category / Product: SERVICES, PARTICLE ENGINEERING, BIOLOGICS, CHEMICAL-SYNTHETIC

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Region: Europe

네덜란드

CARBOGEN AMCIS | Veenendaal

CARBOGEN AMCIS

콜레스테롤 및 비타민 D 유사체의 대규모 제조.

우리 시설을 찾아보세요

Use: Human, Veterinary

BSL (Biological Safety Level): 1

Compliance: DIGEMID, BRCGS, ISO, FDA (cGMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, PMDA/MHLW (Japan GMP), TITCK (Turkish Health Authorities), INVIMA, ECOVADIS, TGA (Australia GMP), ISP (Chile BPM), French Service-Public (CIR), ANMAT (Argentina nueva GMP), NMPA (China GMP), Health Canada (Canada GMP), MHRA (UK GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), NSF, SQF (Safe Quality Food), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), Russian Health Authorities, CDSCO (India), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia), 나머지 세계

Services: Development services, Logistics, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services

Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V09-10) Radiopharmaceuticals, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

Batch Size: Small

Category / Product: SERVICES, CHEMICAL-SYNTHETIC

Region: Europe

스위스

CARBOGEN AMCIS | Neuland

CARBOGEN AMCIS

개발 및 중간 규모 제조.

우리 시설을 찾아보세요

Use: Human, Veterinary

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), CDSCO (India), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)

Services: Development services, Analytical / QC services, Regulatory services, Manufacturing services, Quality Assurance services

Compliance: FDA (cGMP), PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP)

Batch Size: Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: SERVICES, CHEMICAL-SYNTHETIC

Region: Europe

스위스

CARBOGEN AMCIS | Vionnaz

CARBOGEN AMCIS

크로마토그래피 및 동결건조를 포함한 매우 강력한 API 개발 및 소규모 cGMP 생산.

우리 시설을 찾아보세요

Services: Development services, Analytical / QC services, Quality Assurance services, Manufacturing services

Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), CDSCO (India), TGA (Australia)

Compliance: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

Use: Human, Veterinary

Batch Size: Small

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Region: Europe

Category / Product: CHEMICAL-SYNTHETIC

독일

Glatt Pharmaceutical Services GmbH Co. & KG

독일 Binzen에 본사를 두고 복잡한 경구용 고형제 분야의 엔드투엔드 서비스를 위한 cGMP 준수 CDMO입니다.

우리 시설을 찾아보세요

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1

Markets: FDA (USA), EMA (EU)

Services: Development services, Analytical / QC services, Manufacturing services

Compliance: FDA (cGMP), EMA (EU GMP)

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use

Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

스페인

Laboratorios Grifols | Barcelona Plant

Grifols International

유연한 백과 바이알에 담긴 멸균 제조 솔루션(소분자).

우리 시설을 찾아보세요

Batch Size: Large, Small, Medium

Use: Human, Veterinary

Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), ANMAT (Argentina), TGA (Australia)

Services: Development services, Logistics, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services

Compliance: ISO, FDA (cGMP), ANVISA (Brazil B-GMP), INVIMA, ECOVADIS, TGA (Australia GMP), ISP (Chile BPM), ANMAT (Argentina nueva GMP), Health Canada (Canada GMP), MHRA (UK GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse

Therapeutic Areas of Expertise (ATC): (N) Nervous system, (M) Musculoskeletal system, (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

독일

Adragos Pharma | Leipzig

Adragos Pharma

비멸균 반고체 및 액상 의약품.

우리 시설을 찾아보세요

Batch Size: Large, Small, Medium

Use: Human, Veterinary

Markets: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea)

Services: Logistics, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse, High potential for abuse & medical use

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Compliance: EMA (EU GMP)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

스페인

Laboratorio REIG JOFRE, SA (TOLEDO PLANT)

LABORATORIO REIG JOFRE SA

베타락탐 항생제(FDF) 개발 및 최첨단 시설 제조.

우리 시설을 찾아보세요

Batch Size: Large, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1

Compliance: DIGEMID, ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ECOVADIS, ISP (Chile BPM), World Health Organization (GMP / HACCP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP)

Markets: EMA (EU), ANVISA (Brazil), ISP (Chile), DIGEMID (Peru), MHRA (UK), Russian Health Authorities, SFDA (Saudi Arabia), INVIMA (Colombia), TGA (Australia)

Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

Therapeutic Areas of Expertise (ATC): (J) Antiinfectives for systemic use

Controlled Substances: Lowest potential for abuse

Category / Product: FDF / DRUG PRODUCTS

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Region: Europe

네트워크의 더 많은 시설

연락처 및 위치가 포함된 전체 카탈로그를 잠금 해제하려면 등록하세요.

+59개 이상의 시설

무료 계정 만들기

동물보건 산업은 인체 의약품과 동일한 엄격함, 혁신 및 품질 기준을 요구합니다. 수의학 CDMO(계약 개발 및 제조 조직)는 반려동물 치료부터 가축 건강 솔루션까지 수의학 제품의 개발 및 제조를 위한 전문 서비스를 제공합니다.

동물용 제품 계약 제조를 위한 파트너를 선택한다는 것은 종별 요구 사항과 시장 역학에 대한 깊은 이해를 바탕으로 맞춤형 제형, 수의학별 규제 전문 지식, 신뢰할 수 있는 글로벌 유통에 접근하는 것을 의미합니다.

동물용 의약품 위탁 제조 파트너를 선택하는 방법

올바른 수의학 CDMO를 선택하려면 기술적 역량 이상의 것이 필요하며, 동물 보건 분야 전반에 걸친 업계 지식과 적응성이 필요합니다. 다음과 같은 CDMO를 고려해보세요.

수의약리학 및 종별 제제에 대한 경험
수의학 규제 기관(EMA, FDA-CVM 등) 준수
복용 형태에 따른 기능: 경구용, 국소용, 주사제, 사료 첨가제 등
수의학 GMP 표준을 위한 강력한 QA/QC 시스템
가축 및 반려동물 제품 모두에서 검증된 실적

강력한 동물용 제품 계약 제조 파트너는 원활한 프로젝트 진행과 성공적인 제품 출시를 보장합니다.

수의학 CDMO가 제공하는 주요 서비스

제형 개발: 다양한 동물 종에 대한 기호성, 안정성 및 투여 경로에 대한 전문 지식입니다.

임상 및 상업 제조: 다양한 수량 및 글로벌 유통을 위한 GMP 준수 생산.

수의학 규제 지원: 유럽, 미국 및 국제 시장에서 CMC 서류 준비 및 등록 지원.

분석 테스트 및 안정성: 효능, 안전성 및 유효 기간을 보장하기 위한 전체 내부 테스트입니다.

맞춤형 포장: 수의학별 포장 형식, 라벨링 및 일련번호 부여 솔루션.

수의학 CDMO와의 파트너십의 장점

동물 건강 전문 지식: 수의학 약동학 및 치료 전달에 대한 전문적인 지식입니다.

다양한 제형 기능: 경구 액제, 분말, 주사제, 페이스트, 국소 젤 등.

비용 효율적인 확장: 소규모 배치 혁신과 대량 생산을 지원하는 유연성.

빠른 출시 시간: 규정 준수로 인해 지연이 줄어들고 글로벌 제품 확장이 지원됩니다.

글로벌 도달범위: 유럽, 북미, LATAM 및 APAC 전역에서 출시를 지원한 경험이 있습니다.